Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Universität des Saarlandes
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Trans Tasman Radiation Oncology Group
Ruijin Hospital
Fondazione Michelangelo
Universität des Saarlandes
Universität des Saarlandes
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
UNICANCER
SWOG Cancer Research Network
Canadian Cancer Trials Group
Martin-Luther-Universität Halle-Wittenberg
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
M.D. Anderson Cancer Center
University College, London
French Innovative Leukemia Organisation
Children's Oncology Group
Asan Medical Center
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
University Hospital Schleswig-Holstein